Switzerland multiplies therapies with the psychedelic trip, industry patents how to get its effect without it
In 2026, Switzerland is the only country in the world where a doctor can request, case by case, authorisation to treat a patient with LSD, psilocybin or MDMA, a mechanism that in under a decade multiplied the number of approved treatments several times over, up to thirty-eight times more in the case of MDMA. Over … CONTINUE READING →